IL6 and liver cancer: Studies have shown that Icariin, a generic flavonoid compound, inhibits the development and growth of liver cancer by regulating the IL-6/JAK2/STAT3 pathway 11 and also inhibits the expression of PD-L1 by targeting protein IκB kinase α, thus regulating immunity 12.